Does ADALIMUMAB-AATY Cause Gait inability? 12 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Gait inability have been filed in association with ADALIMUMAB-AATY (Yuflyma). This represents 0.7% of all adverse event reports for ADALIMUMAB-AATY.
12
Reports of Gait inability with ADALIMUMAB-AATY
0.7%
of all ADALIMUMAB-AATY reports
0
Deaths
7
Hospitalizations
How Dangerous Is Gait inability From ADALIMUMAB-AATY?
Of the 12 reports, 7 (58.3%) required hospitalization.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB-AATY. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB-AATY Cause?
Intentional dose omission (338)
Drug ineffective (151)
Intentional product use issue (151)
Death (132)
Arthralgia (96)
Rheumatoid arthritis (94)
Fatigue (92)
Therapy interrupted (88)
Crohn's disease (87)
Headache (86)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which ADALIMUMAB-AATY Alternatives Have Lower Gait inability Risk?
ADALIMUMAB-AATY vs ADALIMUMAB-ADAZ
ADALIMUMAB-AATY vs ADALIMUMAB-ADBM
ADALIMUMAB-AATY vs ADALIMUMAB-AFZB
ADALIMUMAB-AATY vs ADALIMUMAB-ATTO
ADALIMUMAB-AATY vs ADALIMUMAB-BWWD